Utility of GLP-1R agonists in diabetes requires long term study. (Record no. 21583401)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01145 a2200301 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516081455.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201206s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1756-1833 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1136/bmj.e1451 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | de Oliveira, Jose Mario Franco |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120612 |
245 00 - TITLE STATEMENT | |
Title | Utility of GLP-1R agonists in diabetes requires long term study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | BMJ (Clinical research ed.) |
Date of publication, distribution, etc. | Feb 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | e1451; author reply e1459 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Letter; Comment |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Obesity Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucagon-Like Peptide 1 |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypoglycemic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Overweight |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Peptides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Glucagon |
General subdivision | agonists |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Venoms |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Weight Loss |
General subdivision | drug effects |
773 0# - HOST ITEM ENTRY | |
Title | BMJ (Clinical research ed.) |
Related parts | vol. 344 |
-- | p. e1451; author reply e1459 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1136/bmj.e1451">https://doi.org/10.1136/bmj.e1451</a> |
Public note | Available from publisher's website |
No items available.